H M Golomb

769 total citations
22 papers, 516 citations indexed

About

H M Golomb is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, H M Golomb has authored 22 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 8 papers in Pulmonary and Respiratory Medicine and 8 papers in Oncology. Recurrent topics in H M Golomb's work include Chronic Lymphocytic Leukemia Research (7 papers), Lung Cancer Treatments and Mutations (7 papers) and Lymphoma Diagnosis and Treatment (5 papers). H M Golomb is often cited by papers focused on Chronic Lymphocytic Leukemia Research (7 papers), Lung Cancer Treatments and Mutations (7 papers) and Lymphoma Diagnosis and Treatment (5 papers). H M Golomb collaborates with scholars based in United States and United Kingdom. H M Golomb's co-authors include D Catovsky, Jorge R. Quesada, JD Rowley, JR Testa, JW Vardiman, Elizabeth Barker, S F Williams, Jacob D. Bitran, P C Hoffman and Everett E. Vokes and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

H M Golomb

22 papers receiving 486 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H M Golomb United States 13 265 148 139 130 107 22 516
P Buchinger Austria 13 411 1.6× 127 0.9× 136 1.0× 81 0.6× 124 1.2× 22 632
Kristina Vermaelen Belgium 9 410 1.5× 98 0.7× 84 0.6× 195 1.5× 173 1.6× 15 540
E. Thiel Germany 14 374 1.4× 240 1.6× 130 0.9× 126 1.0× 159 1.5× 42 620
CR Bartram Germany 11 453 1.7× 309 2.1× 109 0.8× 148 1.1× 206 1.9× 17 668
RT Silver United States 9 344 1.3× 155 1.0× 92 0.7× 281 2.2× 149 1.4× 13 580
C Mecucci Italy 16 392 1.5× 131 0.9× 123 0.9× 272 2.1× 293 2.7× 35 765
SA Shurtleff United States 9 377 1.4× 311 2.1× 144 1.0× 117 0.9× 292 2.7× 9 706
JD Tigaud France 7 354 1.3× 56 0.4× 219 1.6× 121 0.9× 162 1.5× 13 539
I. Quiquandon France 12 459 1.7× 71 0.5× 276 2.0× 210 1.6× 226 2.1× 17 774
HM Kantarjian United States 10 545 2.1× 233 1.6× 146 1.1× 446 3.4× 163 1.5× 12 842

Countries citing papers authored by H M Golomb

Since Specialization
Citations

This map shows the geographic impact of H M Golomb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H M Golomb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H M Golomb more than expected).

Fields of papers citing papers by H M Golomb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H M Golomb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H M Golomb. The network helps show where H M Golomb may publish in the future.

Co-authorship network of co-authors of H M Golomb

This figure shows the co-authorship network connecting the top 25 collaborators of H M Golomb. A scholar is included among the top collaborators of H M Golomb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H M Golomb. H M Golomb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Masters, Gregory A., Daniel J. Haraf, P C Hoffman, et al.. (1998). Phase I study of vinorelbine, cisplatin, and concomitant thoracic radiation in the treatment of advanced chest malignancies.. Journal of Clinical Oncology. 16(6). 2157–2163. 41 indexed citations
2.
Masters, Gregory A., et al.. (1998). A review of ifosfamide and vinorelbine in advanced non-small cell carcinoma of the lung.. PubMed. 25(1 Suppl 2). 8–14. 6 indexed citations
3.
Masters, Gregory A., et al.. (1997). Phase I study of vinorelbine and ifosfamide in advanced non-small-cell lung cancer.. Journal of Clinical Oncology. 15(3). 884–892. 17 indexed citations
4.
Vokes, Everett E., D. Haraf, Gregory A. Masters, et al.. (1996). Vinorelbine (Navelbine), cisplatin, and concomitant radiation therapy for advanced malignancies of the chest: a Phase I study.. PubMed. 23(2 Suppl 5). 48–52. 7 indexed citations
5.
Hoffman, P C, S Krauß, Gregory A. Masters, et al.. (1996). Paclitaxel and ifosfamide: A multicenter phase I study in advanced non-small cell lung cancer. Lung Cancer. 14(1). 171–171. 2 indexed citations
6.
Kanost, Michael R., Frederick R. Davey, B. Peterson, et al.. (1995). Recombinant alpha-2b-interferon in therapy of previously untreated hairy cell leukemia: long-term follow-up results of study by Cancer and Leukemia Group B.. PubMed. 9(7). 1116–20. 28 indexed citations
7.
Catovsky, D, DW Golde, & H M Golomb. (1990). THE THIRD INTERNATIONAL WORKSHOP ON HAIRY CELL LEUKEMIA, LAGUNA NIGUEL, CALIFORNIA, 19–20 OCTOBER 1989. British Journal of Haematology. 74(3). 378–379. 3 indexed citations
8.
Williams, S F, et al.. (1990). Peripheral blood-derived stem cell collections for use in autologous transplantation after high dose chemotherapy: an alternative approach.. PubMed. 5(2). 129–33. 74 indexed citations
9.
Mick, Rosemarie, MJ Ratain, & H M Golomb. (1990). Duration of response after interferon treatment of hairy cell leukemia [letter; comment]. Blood. 75(12). 2465–2467. 1 indexed citations
10.
Bloomfield, Clara D., Lorna M. Secker‐Walker, Herman Van den Berghe, et al.. (1989). Six-year follow-up of the clinical significance of karyotype in acute lymphoblastic leukemia. Cancer Genetics and Cytogenetics. 40(2). 171–185. 126 indexed citations
11.
Golomb, H M, MJ Ratain, & Jill Moormeier. (1989). What is the choice of treatment for hairy cell leukemia?. Journal of Clinical Oncology. 7(2). 156–158. 6 indexed citations
12.
Schilsky, Richard L., et al.. (1987). Gonadal and sexual function in male patients with hairy cell leukemia: lack of adverse effects of recombinant alpha 2-interferon treatment.. PubMed. 71(2). 179–81. 13 indexed citations
13.
MacMahon, Heber, et al.. (1986). Postoperative recurrence of lung cancer: detection by whole-body gallium scintigraphy. American Journal of Roentgenology. 147(5). 911–915. 5 indexed citations
14.
Preisler, HD, Azra Raza, Donald J. Higby, et al.. (1984). Treatment of myeloid blastic crisis of chronic myelogenous leukemia.. PubMed. 68(11). 1351–5. 16 indexed citations
15.
Golomb, H M. (1983). Non-small cell carcinoma of the lung.. PubMed. 10(1). 1–122. 12 indexed citations
16.
Martin, Paulette, B. Levin, H M Golomb, & Robert H. Riddell. (1979). Chromosome analysis of primary large bowel tumors.A new method for improving the yield of analyzable metaphases. Cancer. 44(5). 1656–1664. 22 indexed citations
17.
Testa, JR, et al.. (1978). Hypergranular promyelocytic leukemia (APL): cytogenetic and ultrastructural specificity. Blood. 52(2). 272–280. 48 indexed citations
18.
Jd, Bitran, et al.. (1977). Megaloblastic anemia during pregnancy.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 19(4). 186–92. 2 indexed citations
19.
Berghe, Herman Van den, G.H. Borgström, L. Brandt, et al.. (1977). Chromosomes in leukemia. Cytogenetic and Genome Research. 19(6). 321–325. 14 indexed citations
20.
Golomb, H M. (1976). Partial deletion of long arm of chromosome 17: a specific abnormality in acute promyelocytic leukemia?. Archives of Internal Medicine. 136(7). 825–828. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026